Alimera Sciences

1 Follower


Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Rick Eiswirth
President and Chief Executive Officer
Rick Eiswirth
David Holland
Chief Marketing Officer, SVP Corporate Communications and Managed Markets
Phil Jones
Chief Financial Officer
Philip Ashman
Chief Operating Officer, SVP, Commercial Operations Europe
David Dyer M.d.
Chief Retina Specialist

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.